Jump Financial’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.6M | Buy |
17,177
+1,460
| +9% | +$476K | 0.06% | 368 |
|
|
2025
Q1 | $4.24M | Buy |
15,717
+572
| +4% | +$154K | 0.06% | 365 |
|
|
2024
Q4 | $3.56M | Buy |
+15,145
| New | +$3.56M | 0.07% | 347 |
|
|
2024
Q2 | – | Sell |
-17,554
| Closed | -$2.62M | – | 1765 |
|
|
2024
Q1 | $2.62M | Buy |
17,554
+10,262
| +141% | +$1.53M | 0.07% | 339 |
|
|
2023
Q4 | $1.4M | Buy |
+7,292
| New | +$1.4M | 0.04% | 536 |
|
|
2023
Q3 | – | Sell |
-8,439
| Closed | -$1.6M | – | 1805 |
|
|
2023
Q2 | $1.6M | Sell |
8,439
-21,337
| -72% | -$4.05M | 0.06% | 466 |
|
|
2023
Q1 | $5.96M | Buy |
29,776
+23,748
| +394% | +$4.76M | 0.24% | 114 |
|
|
2022
Q4 | $1.43M | Buy |
6,028
+4,704
| +355% | +$1.12M | 0.08% | 348 |
|
|
2022
Q3 | $265K | Buy |
+1,324
| New | +$265K | 0.01% | 1210 |
|